We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Provexis Plc | PXS | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.575 | 08:00:10 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.575 |
| Industry Sector |
|---|
| FOOD PRODUCERS |
| Top Posts |
|---|
Posted at 07/3/2025 06:38 by sigma3333 The aspirin and cancer articles surface every couple of years and so far have led to nothing. I’m sure BH have it on their list of things to do but pxs won’t see any benefit.Something really isn’t clicking here. No blue cap, no oriri travel, no sircoheart, what is holding FF back ? siggy |
Posted at 26/2/2025 18:21 by gix er I agree Bareknee, well to the first part anyway.Not sure if PXS would allow FF to be manufactured in China under licence though. |
Posted at 25/2/2025 09:22 by winner31 With the “early months” nearly gone , do we think it is too late for Pxs to have an open offer for the funding we need ? The bod must surely know by now the requirements of existing and new customers for the next 24 months , or have they given millions of shares at a huge discount to Dsm ,By-health or SL .I don’t suppose we will know unless they release an Rns ,I’m not holding my breath on that one . |
Posted at 08/1/2025 17:40 by redprince winner - the fact that the new options are at an average of 0.37 is far from encouraging.Ofc we do not know the performance conditions attached to them.The RNS imo should have been less ambiguous in terms of detailing the performance conditionality and also clear as to what change of control means. Fwiw i will be resolutely opposed to any t/o approach before we can ascertain the worth of the Chinese deal and doubly opposed to any attempt by Lucas to take us private or any attempt to delist pxs from AIM. |
Posted at 07/1/2025 17:14 by redprince This latest news is even by pxs standards simply staggering.1% of the company handed to a director at an appallingly low strike price.It sends a very poor message to investors and the wider market. Absolutely appalling. |
Posted at 01/1/2025 10:05 by huntergls The only disappointment from the update for me was as informer said no update on the last 3 months figures. But as we need to make a large batch of fruitflow for start of 2025 and beyond I am not to worried. Money I guess will be raised when bi-health announce blue cap which I hope will be in the first few months of 2025. I am sure then he will have no issues getting investors to buy in. RP, yes 15 years is a long time but it is what it is. Moaning all the time won't make you feel any better. IMO this is now the best position we have bin in since it started. 2025 should be a great year for PXS. For me I will hopefully increase my 1.6% to 2% this year. And one final thing RP, AIM shares are a casino. GLA |
Posted at 23/10/2024 06:17 by sigma3333 redprinceI recall PXS were given a dressing down over the concert party raid in 2009 - the former CEO indeed took the opportunity to make a significant profit from stock options. Although only my opinion, I believe the current CEO behaviour is to avoid another P&D. The one person that has kept PXS going is gixer - in fact the latest find around from Duttaroy is very exciting. The CEO has lived off the prospect of blue cap/China for nearly 10 years now. If it doesn’t happen by end of this year then I believe time for a SR. (by the way I firmly believe gixer is the curent CEO, or works for PXS). siggy |
Posted at 15/8/2024 16:16 by bareknee SmithiePart of what you say is true, but to get there your workings out are a bit ropey. The bit that I'd say you're right about relates to cashflow and PXS having to, or choosing to, issue shares to DSM Firmenich as part payment for a batch of FF. When the results come out in September we'll know, or have a very good idea, as to whether or not we had the cash to pay for that FF and continue operating or not. I suspect we didn't, so it was a way of keeping the wheels turning until we're either cashflow positive, can borrow against future sales or issue more shares in a placing. So there's a big risk there. Where your working out is dodgy relates to the B2B relationship between PXS and DSM. They don't make Fruitflow, they just have some in store which they pretty much can't sell to anyone except PXS, so it's an unusual situation and will likely unravel quite soon ( if it hasn't already ). At that point PXS will have to go to the manufacturer which supplied FF to DSM and negotiate a contract. The issues on cashflow will almost certainly be the same as they are between us and DSM now and, if they can't be resolved, then it's Goodnight Vienna time. Previously our Chief Exec has been able to keep things going via placings,so that's the obvious route to go. What we don't know is if, or more likely when the Chinese company ByHealth, who want to launch over there, will get permission from their regulator. If they get that permission in a timely manner and put decent sized orders in, then borrowing against that gets much easier, as does convincing people to take part in a placing. At that point the hope is that PXS is then profitable, has manageable cashflow and becomes a proper business. What the share price was years ago is immaterial. It was plainly massively overvalued, but that's in the past. |
Posted at 15/8/2024 14:43 by smithie6 ...one can look at it from different viewpointsone viewpoint is that the co. does not have enough cash to buy product from a stockist imo that is bad & it probably continues a never ending sequence of dilution & more dilution ... imo that is also bad. ---- & from my viewpoint the owner of the IP, PXS, should be receiving cash generated from sales which for PXS should imo be globally located re-sellers/agents so, imo, PXS should not be buying stock from a seller, the seller should be selling it shops & Joe Public....it infers that the agent was not able to sell it, imo. stock coming back to PXS is not a +ve sign imo |
Posted at 13/8/2024 19:23 by smithie6 ..what's the story here nowadays ?...the owns intel. prop. in some food product which apparently has some health benefits, yes ? but to obtain the product to then supply it to others the co. has to issue a lot of shares to some overseas third party, who apparently make the product, yes ? so, one assumes that PXS itself is virtually bankrupt since it can not pay cash to obtain its own product, to then sell it (at a higher price) All seems "very strange" to me. Surely, normal business practice would be that the mfr makes the stuff, supplies it to PXS (with an invoice asking to be paid) & PXS ships the stuff to clients for cash on delivery or cash in say 10 days. And then PXS pays the product mfr, within 60-90 days. And everyone is happy. And PXS keeps the nett gross profit on its sales. Step & repeat. but no, PXS issues 2% of the shares of PXS to the product mfr. !! seems insane to me. The only logical justification I can see is that PXS is verging on bankruptcy & no one is willing to supply the product without getting paid at delivery, & PXS can not pay, since it pays using shares. It all seems a bit strange imo. ====== Other companies that have relentlessly issued new shares include Craven House. Another disaster. ---- looking at the "all time" chart for PXS, it looks similar perhaps to a hospital monitor display for someone and the last activity on the monitor was in 2010 ! ...& that since then it has just flat lined ! While on the 2 year chart it looks like the sick patient briefly wakes up once per year...only to then slide further downhill ! |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
